Home
>
National Drug Code (NDC)
>
Gemcitabine
Gemcitabine - 0409-0185-01 - (GEMCITABINE HYDROCHLORIDE)
Drug Information of Gemcitabine
| Product NDC: | 0409-0185 |
| Proprietary Name: | Gemcitabine |
| Non Proprietary Name: | GEMCITABINE HYDROCHLORIDE |
| Active Ingredient(s): | 38 mg/mL & nbsp; GEMCITABINE HYDROCHLORIDE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Gemcitabine
| Product NDC: | 0409-0185 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078339 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110725 |
Package Information of Gemcitabine
| Package NDC: | 0409-0185-01 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0409-0185-01) > 5.26 mL in 1 VIAL, SINGLE-USE |
NDC Information of Gemcitabine
| NDC Code | 0409-0185-01 |
| Proprietary Name | Gemcitabine |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0409-0185-01) > 5.26 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0409-0185 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | GEMCITABINE HYDROCHLORIDE |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110725 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | GEMCITABINE HYDROCHLORIDE |
| Strength Number | 38 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
